DialysisPPO
Curated by SignalEnd-stage renal disease cost containment solutions to the health plan market.
Overview
DialysisPPO provides end-stage renal disease cost containment solutions to the health plan market. The company's patented program enables employer group health plans to capitalize on the unique Medicare reimbursement aspects of this costly disease. The company claims that average client savings is approximately $590,000 per dialysis case per annum.
Key facts
- Founded
- 2006
- Headquarters
- King Of Prussia, United States
- Stage
- Sign up to view
- Industry
- Health Technology
Business model
- 2 products and services
- Sign up to view
Contact
- Primary office
- Sign up to view